Sonopeace
Top PickSonopeace is our top pick because it is the only device here with a double-blind, placebo-controlled clinical trial showing it improves sleep, and it does so with nothing to wear and no subscription for the device itself.
Sonopeace is a bone-conduction sound therapy device that sits under your pillow. Instead of tracking your night, it delivers gentle acoustic stimulation intended to encourage the slow-wave activity that defines deep, restorative sleep. There is nothing on your wrist or finger, nothing to charge on your body, and no morning score to interpret.
Best for: Adults with poor or disrupted sleep who want to improve it, not just measure it, and who prefer a contactless, medication-free approach.
- The only device in this roundup validated by a double-blind, placebo-controlled clinical trial for improving sleep.
- Contactless. It works under your pillow, so there is nothing to wear.
- No subscription for the device. It is a one-time purchase with no recurring fee. The companion app is included free for 6 months, then continues by subscription.
- The companion app explains in plain language why you slept the way you did, gives you one thing to change tonight, and shows whether the device is helping night by night, rather than returning a raw score alone.
- Medication-free and non-habit-forming, with benefits that persisted after use stopped in the trial.
- Improves sleep quality without sedation, so it is designed not to leave you groggy.
- The device itself has no sensor and does not measure your sleep. The companion app adds tracking and advice, but it reads from a wearable you already own, such as an Apple Watch, Oura Ring, or Fitbit. If you do not own one of those, you get no nightly metrics.
- It is single-purpose. It focuses on sleep and does not measure activity, recovery, or other wellness metrics.
- It is pre-order and coming soon. The store is in early access, so you join a waitlist today rather than buying immediately.
- The locked public evidence is one SLEEP 2026 meeting abstract (N = 45 crossover). That is a modest sample and a single evaluation.
- The published cite is a meeting abstract of preliminary analyses, not a full peer-reviewed paper, and it has not been independently replicated.
Evidence: Sonopeace has been clinically studied in a 45-adult crossover evaluation, published as a SLEEP 2026 meeting abstract (Okun, Dennis, McNair; DOI: 10.1093/sleep/zsag091.1282). Protocol A showed no significant objective-sleep changes from baseline to placebo; light-sleep and REM-sleep proportions, and time awake after falling asleep improved from placebo to Sonopeace (P’s < .01), and daytime sleepiness, insomnia symptoms, and general sleep disturbance improved only after Sonopeace. Protocol B showed significant improvements in deep-sleep proportion and time awake after falling asleep from baseline to Sonopeace, with additional sleep efficiency and REM-sleep proportion from Sonopeace to the later placebo period. Subjective measures except daytime sleepiness improved after Sonopeace and were sustained during subsequent placebo. This is a meeting abstract — preliminary analyses — not a full peer-reviewed paper. Read the citation and protocol notes.
Price / subscription: Pre-order / early access. Pricing is announced at launch, and the device requires no subscription. The companion app is included free for 6 months with every device, then continues by subscription.
See how Sonopeace compares to sleep trackers Read verified Sonopeace reviews